clinical parameters | total | NLR | p-value | PLR | p-value | ||
---|---|---|---|---|---|---|---|
LNLR (n = 113) | HNLR (n = 50) | LPLR (n = 90) | HPLR (n = 73) | ||||
age (year) | 38.49 ± 11.10 | 38.29 ± 11.18 | 38.94 ± 11.03 | 0.732 | 39.07 ± 10.48 | 37.78 ± 11.86 | 0.464 |
Sex | |||||||
 Male | 91 | 63 | 28 | 0.977 | 49 | 42 | 0.693 |
 Female | 72 | 50 | 22 |  | 41 | 31 |  |
Companacci stage | |||||||
 I-II stage | 86 | 70 | 16 | < 0.001 | 59 | 27 | < 0.001 |
 III stage | 77 | 43 | 34 |  | 31 | 46 |  |
tumor diameter (cm) | 5 (4~7) | 5 (4~6) | 6 (5~8) | 0.048 | 5 (4~6) | 6 (5~8) | 0.006 |
ALP(U/L) | 79 (63~122) | 76 (62~121) | 98 (64~136) | 0.047 | 73 (59~107) | 91 (68~124) | 0.008 |
white blood cell (109/L) | 6.03 (5.12~7.06) | 6.01 (5.13~6.79) | 6.20 (5.04~7.30) | 0.450 | 5.95 (5.05~7.06) | 6.20 (5.15~7.04) | 0.544 |
neutrophil (%) | 55.4 (50.0~61.6) | 52.6 (47.8~56.2) | 63.6 (61.4~68.4 | < 0.001 | 54.6 (48.8~60.7) | 57.1 (50.6~63.2) | 0.120 |
lymphocytes(%) | 29.5 (24.2~36.6) | 33.8 (29.2~38.9) | 22.2 (18.9~24.3) | < 0.001 | 31.1 (25.6~37.1) | 28.2 (23.8~34.2) | 0.117 |
platelet (109/L) | 232 (195~272) | 231 (191~266) | 246 (200~290) | 0.159 | 203 (165~235) | 274 (242~314) | < 0.001 |
ESR (mm/h) | 17 (9~34) | 16 (9~34) | 19 (10~36) | 0.439 | 16 (8~37) | 21 (10~34) | 0.471 |
CRP (mg/L) | 8.16 (3.77~13.57) | 7.64 (3.65~11.93) | 12.51 (4.05~23.38) | 0.043 | 6.52 (3.44~11.89) | 10.59 (4.39~25.85) | 0.005 |